IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

REPETTO, MATTEO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.212
AS - Asia 1.079
NA - Nord America 909
SA - Sud America 110
AF - Africa 33
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.351
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 875
DE - Germania 653
SG - Singapore 307
CN - Cina 276
IT - Italia 195
HK - Hong Kong 119
VN - Vietnam 97
BD - Bangladesh 94
FR - Francia 90
BR - Brasile 86
IN - India 78
SE - Svezia 72
RU - Federazione Russa 70
GB - Regno Unito 39
NL - Olanda 31
FI - Finlandia 21
JP - Giappone 20
CA - Canada 17
ID - Indonesia 17
TR - Turchia 16
IE - Irlanda 15
CI - Costa d'Avorio 14
KR - Corea 13
AT - Austria 9
MX - Messico 9
AR - Argentina 8
AU - Australia 7
TW - Taiwan 7
PH - Filippine 6
AE - Emirati Arabi Uniti 5
UA - Ucraina 5
EC - Ecuador 4
IQ - Iraq 4
KE - Kenya 4
NG - Nigeria 4
CL - Cile 3
JM - Giamaica 3
MY - Malesia 3
PL - Polonia 3
SA - Arabia Saudita 3
TN - Tunisia 3
VE - Venezuela 3
CH - Svizzera 2
CO - Colombia 2
EG - Egitto 2
JO - Giordania 2
PE - Perù 2
TT - Trinidad e Tobago 2
UZ - Uzbekistan 2
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
CR - Costa Rica 1
DK - Danimarca 1
DZ - Algeria 1
ES - Italia 1
GA - Gabon 1
GT - Guatemala 1
HU - Ungheria 1
IL - Israele 1
IR - Iran 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
LT - Lituania 1
MA - Marocco 1
MD - Moldavia 1
OM - Oman 1
PA - Panama 1
PK - Pakistan 1
PY - Paraguay 1
RS - Serbia 1
SC - Seychelles 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZA - Sudafrica 1
Totale 3.351
Salva come PNG Salva come JPEG
Città #
Frankfurt am Main 614
Ashburn 178
Singapore 135
Hong Kong 107
Dallas 76
San Jose 70
Santa Clara 66
Hefei 61
Milan 48
Chandler 42
Council Bluffs 41
New York 41
Los Angeles 36
Beijing 35
Hanoi 30
Boardman 29
Bengaluru 24
Moscow 24
Ho Chi Minh City 23
Lauterbourg 21
Buffalo 19
Chennai 16
Dublin 15
Abidjan 14
Helsinki 14
Tokyo 13
Southend 12
Antibes 11
Hyderabad 11
Istanbul 11
Jakarta 10
Rome 10
Princeton 9
Seoul 9
Munich 8
Guangzhou 7
Naples 7
Nuremberg 7
Orem 7
Brooklyn 6
Charlotte 6
Da Nang 6
Palermo 6
Seattle 6
Shanghai 6
São Paulo 6
Wuhan 6
Atlanta 5
Bari 5
Berlin 5
Columbus 5
London 5
Phoenix 5
Roubaix 5
Turin 5
Washington 5
Ankara 4
Bexley 4
Cambridge 4
Chicago 4
Dong Ket 4
Düsseldorf 4
Florence 4
Lagos 4
Lappeenranta 4
Marietta 4
Marseille 4
Montreal 4
Osaka 4
Paris 4
Ponte San Pietro 4
Porto Alegre 4
Rimini 4
Sydney 4
Toronto 4
Vallauris 4
Abu Dhabi 3
Baghdad 3
Belmont 3
Bologna 3
Cangzhou 3
Cusano Milanino 3
Des Moines 3
Manila 3
Mumbai 3
Neoules 3
Portsmouth 3
Quanzhou 3
Santiago 3
Shenzhen 3
Amman 2
Arezzo 2
Aryanah 2
Bollate 2
Boston 2
Brisbane 2
Bắc Giang 2
Bến Tre 2
Cairo 2
Can Tho 2
Totale 2.146
Salva come PNG Salva come JPEG
Nome #
High-performance prediction models for prostate cancer radiomics 293
Systemic Treatment of Ductal Carcinoma In Situ of the Breast 246
The Immune-related adverse event (IRAE) Likelihood Score (ILS) identifies “pure” IRAEs strongly associated with outcome in a phase I-II trial population 241
Thymic carcinoma with Lynch syndrome or microsatellite instability, a rare entity responsive to immunotherapy 223
Precision medicine in breast cancer : From clinical trials to clinical practice 193
A set of easy and stringent criteria to identify immune-related adverse events (IrAE Scoring System, ISS) improves correlation with outcome in a phase 1-2 trial population 193
Research and clinical landscape of bispecific antibodies for the treatment of solid malignancies 184
A robust goal programming model for transfer pricing risk hedging: Preliminary results 181
ESMO recommendations on the standard methods to detect RET fusions and mutations in daily practice and clinical research 180
Selective FGFR/FGF pathway inhibitors: inhibition strategies, clinical activities, resistance mutations, and future directions 177
A dynamic approach to supply chain reconfiguration and ripple effect analysis in an epidemic 171
Immune-related adverse events are correlated with significantly improved outcome in a phase I trial population exposed to combination immunotherapy 159
Evaluation of the Geographical Accessibility of Genome-Matched Clinical Trials on a National Experience 156
Molecular tumor board in patients with metastatic breast cancer 144
Immune-Related Adverse Event Likelihood Score Identifies “Pure” IRAEs Strongly Associated With Outcome in a Phase I-II Trial Population 124
Molecular tumour board at European Institute of Oncology: Report of the first three year activity of an Italian precision oncology experience 118
The Safety and Suitability of DNA Sequencing of Tissue Biopsies Performed on Patients Referred to a Phase I Unit 118
Clinical actionability of BRCA2 alterations in uterine leiomyosarcoma: a molecular tumor board case report and a cBioPortal comprehensive analysis 111
Cancers of Unknown Primary Origin: Real-World Clinical Outcomes and Genomic Analysis at the European Institute of Oncology 105
Deleterious alterations in homologous recombination repair genes and efficacy of platinum-based chemotherapy in biliary tract cancers 86
Challenges and Obstacles in Applying Therapeutical Indications Formulated in Molecular Tumor Boards 7
Genomic landscape of breast cancer in elderly patients 7
null 6
The return of RET GateKeeper mutations? an in-silico exploratory analysis of potential resistance mechanisms to novel RET macrocyclic inhibitor TPX-0046 6
A demand-offer critical analysis of current drug development. Phase I drugs versus TCGA sequencing data 6
The emerging role of PI3K inhibitors for solid tumour treatment and beyond 6
Antibody-Drug Conjugates in Breast Cancer: What Is beyond HER2? 6
Molecular tumour board in gastrointestinal cancers 6
Variant allele frequency: a decision-making tool in precision oncology? 4
AI/ML and drug repurposing in lung cancer: State of the art and potential roles for retinoids 3
Artificial intelligence in small-molecule drug discovery 3
Targeting Cellular Components of the Tumor Microenvironment in Solid Malignancies 1
Beyond PD(L)-1 Blockade in Microsatellite-Instable Cancers: Current Landscape of Immune Co-Inhibitory Receptor Targeting 1
Totale 3.465
Salva come PNG Salva come JPEG
Categoria #
all - tutte 8.452
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.452
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202116 0 0 0 0 0 0 0 0 0 0 0 16
2021/202273 3 4 3 6 4 7 4 9 8 6 6 13
2022/2023180 26 17 18 8 14 21 0 16 34 2 16 8
2023/2024601 11 18 15 19 56 25 92 76 36 78 88 87
2024/2025753 79 89 70 71 33 30 13 69 54 71 71 103
2025/20261.836 213 189 199 172 100 62 215 53 151 103 194 185
Totale 3.465